Equity Research, Broker Reports, and media content on PROMIS NEUROSCIENCES INC

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about PROMIS NEUROSCIENCES INC
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on PROMIS NEUROSCIENCES INC. We currently have 0 research reports from 0 professional analysts.

Open
0.30
Volume
0.3m
Range
0.30/0.30
Market Cap
62,369,025m
52 Week
0.00/0.30
Date Source Announcement
24May17 12:30 GNW ProMIS Neurosciences Designates PMN350 its Second Lead Product for Development in Alzheimer's Disease
09May17 12:30 GNW ProMIS Neurosciences Announces Q1 2017 Annual Results
27Apr17 12:30 GNW ProMIS Neurosciences to announce results in a presentation at the 2017 American Association of Neurology annual meeting
12Apr17 13:30 GNW ProMIS Neurosciences announces results presented at the 13th International Conference on Alzheimer's and Parkinson's diseases held in Vienna, Austria
30Mar17 12:30 GNW ProMIS Neurosciences announces overview of first quarter 2017 progress and outlook for near term value creation
28Mar17 12:30 GNW ProMIS Neurosciences announces presentation and expert panel participation at the Neuroscience Biopartnering and Investment Forum held on March 27, 2017 at the New York Academy of Sciences
22Mar17 13:00 GNW ProMIS Neurosciences Announces Appointment of Daniel Geffken as Chief Financial Officer
  • Frequency of research reports

     

  • Research reports on

    PROMIS NEUROSCIENCES INC

  • Providers covering

    PROMIS NEUROSCIENCES INC